Back to results
US 2025/0027942 A1Published application
Covid-19 theranostic
AssigneeUniversite Libre de Bruxelles
InventorNathalie DE VOS
Life of this patent
Estimating the term…
Abstract
A diagnostic based on Angiotensin 1-7 level, possibly in synergy with other blood parameters, to predict the outcome of infected patients by respiratory viral diseases and the corresponding drugs to prevent worsening of the disease for the patients predicted to be at higher risk.
Claims20
A method to predict whether a patient infected by a viral respiratory disease is at risk of developing clinical complications, the method comprising:
- measuring at least one of an Angiotensin (1-7) level, a C reactive protein (CRP) level, and a ferritin level in a blood sample of the patient at admission;
- and
- comparing the levels measured in the blood sample with at least one of (i) a level found in patients infected by the viral respiratory disease and known to have a favorable outcome or (ii) a level found in patients infected by the viral respiratory disease and known to have a poor outcome,
- wherein the viral respiratory disease is a SARS infection.
1 more element
Dependencies are inferred from the claim text.